Research News and Research

RSS

Case Western Reserve researchers breed a "Lance Armstrong" mouse

Case Western Reserve University researchers have bred a line of "mighty mice" (PEPCK-Cmus mice) that have the capability of running five to six kilometers at a speed of 20 meters per minute on a treadmill for up to six hours before stopping.

2 Nov 2007

Argonne and IBM accelerate the coming era of petascale computation

IBM and the U.S. Department of Energy's Argonne National Laboratory announced completion of a contract for a 445-teraflops Blue Gene/P system for the Argonne Leadership Computing Facility (ALCF).

2 Nov 2007

Review of aspirin therapy

Aspirin, long known to relieve fevers, aches and pain, has served an increasingly bigger role in health care in recent years.

2 Nov 2007

Acupuncture and Western-style medicine

Acupuncture, one of the oldest medical therapies in the world, is steadily gaining popularity in the United States.

2 Nov 2007

Blood gene expression signatures predict exposure levels

In a new study, researchers found they could detect toxic levels of acetaminophen in laboratory animals by analyzing gene expression in the blood.

1 Nov 2007

Threshold for colectomy may be too high, warn experts

The clinical threshold for undertaking elective surgery to remove part or all of the colon (colectomy) for people with inflammatory bowel disease (IBD) may be too high, warn researchers in a study published on bmj.com.

1 Nov 2007

Study finds some middle schoolers in rural areas are drinking and driving

Warnings that alcohol and driving don't mix are generally targeted at adults or high school students, but a new University of Georgia study finds that some middle schoolers in rural areas are drinking and driving as well.

1 Nov 2007

Discovery of gene variant linked to prostate cancer in African Americans

Researchers report a newly identified genetic variation that is linked to higher incidence of prostate cancer in African American men.

1 Nov 2007

Search for new uses for heroin and marijuana

The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.

1 Nov 2007

Bevacizumab improves ovarian cancer treatment

A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.

1 Nov 2007

Scientists to map lethal bacteria in three dimensions

A scientist slides on a pair of plastic 3-D glasses and an unearthly blue multi-armed creature -- an image right out of a sci-fi horror flick -- seems to leap out of the computer screen into the laboratory.

1 Nov 2007

New tool helps pharmacies cater for customers with poor health literacy

The U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality today announced two new tools to help pharmacies provide better quality services to people with limited health literacy.

1 Nov 2007

New genetic variant associated with prostate cancer in African-Americans

Two tiny genetic variations may provide the best clues yet for finding more precise ways to estimate prostate cancer risk and improve screening and early detection for men of African descent, report researchers from the University of Chicago and the Translational Genomics Research Institute, Phoenix, AZ, in the December 2007 issue of Genome Research, published early online.

1 Nov 2007

Merck Serono and EPFL announce neuroscience, oncology and drug delivery partnership

Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.

1 Nov 2007